The 8th International Nanotoxicology Congress (Nanotox 2016) is dedicated to research findings regarding the safe implementation of nanotechnology from a highly interdisciplinary perspective.
The 8th International Nanotoxicology Congress (Nanotox 2016) covers topics such as:
- Standardization for nanomaterial genotoxicity testing for regulatory impact
- Implications from nanoparticles released across life cycle of nano-enabled products: Exposures and risks beyond occupational settings with emphasis on implications at consumer level and end of life
- Adverse outcome pathways and systems biology approaches in nano-risk science
- Nanotoxicology’s impact on nanocommercialization
- Alternative testing strategies, categorization, and decision-making framework for nano-EHS regulatory purposes
- Nanoceria: benefits and risks
- Nanoparticle dosimetry: Concordance between in vitro and in vivo model systems
- Influence of nanoparticle-biocorona on cellular responses
- Nanotechnology for neuroscience
- Lessons from the real world: What is human nanotoxicology telling us?
- Environmental exposures to nanomaterials: Methods, approaches, detection, and modeling
- PBPK modeling of nanoparticle biodistribution
- New breakthroughs in ENM toxicity assessment
- Green nanomaterials: the fusion product of green chemistry/toxicology with nanotoxicology
- Lessons from mouse models of susceptibility to ENM-induced lung disease
- Ramifications of nanomaterials exposures on the maternal-fetal interface and prenatal development
- Emerging nanomaterials: What’s next?
The 8th International Nanotoxicology Congress (Nanotox 2016) brings together scientists from academia, industry, government agencies, and non-governmental organizations.
